We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.3B
AUM Growth
+$247M
Cap. Flow
+$141M
Cap. Flow %
6.12%
Top 10 Hldgs %
17.75%
Holding
321
New
26
Increased
135
Reduced
107
Closed
32

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$27M
2
REVG
REV Group
REVG
+$18.6M
3
DBD
Diebold Nixdorf Incorporated
DBD
+$17.2M
4
WGO icon
Winnebago Industries
WGO
+$10.7M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$9.54M

Top Sells

Rank Stock Value
1
CEB
CEB Inc.
CEB
+$22.7M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$20.1M
3
HELE icon
Helen of Troy
HELE
+$20M
4
ALOG
Analogic Corp
ALOG
+$18.5M
5
AMRI
Albany Molecular Research Inc
AMRI
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 18.67%
3 Industrials 18.25%
4 Consumer Discretionary 13.65%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MD icon
301
Pediatrix Medical
MD
$2.09B
– –
-22,994
Closed -$1.59M
NDSN icon
302
Nordson
NDSN
$17.1B
– –
-18,589
Closed -$2.28M
NSP icon
303
Insperity
NSP
$2B
– –
-44,366
Closed -$1.97M
ONTO icon
304
Onto Innovation
ONTO
$14.6B
– –
-71,901
Closed -$2.19M
PBPB
305
DELISTED
Potbelly
PBPB
– –
-170,506
Closed -$2.37M
BCOV
306
DELISTED
Brightcove, Inc.
BCOV
– –
-174,032
Closed -$1.55M
ATRI
307
DELISTED
Atrion Corp
ATRI
– –
-1,917
Closed -$898K
SYNH
308
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-437,938
Closed -$20.1M
EGOV
309
DELISTED
NIC Inc
EGOV
– –
-430,070
Closed -$8.69M
GPOR
310
DELISTED
Gulfport Energy Corp.
GPOR
– –
-597,704
Closed -$10.3M
NCI
311
DELISTED
Navigant Consulting, Inc.
NCI
– –
-97,817
Closed -$2.24M
CIVI
312
DELISTED
Civitas Solutions, Inc.
CIVI
– –
-77,563
Closed -$1.42M
BOJA
313
DELISTED
Bojangles', Inc. Common Stock
BOJA
– –
-88,596
Closed -$1.82M
ALOG
314
DELISTED
Analogic Corp
ALOG
– –
-244,116
Closed -$18.5M
BSFT
315
DELISTED
BroadSoft, Inc.
BSFT
– –
-364,968
Closed -$14.7M
SSNI
316
DELISTED
Silver Spring Networks, Inc.
SSNI
– –
-114,143
Closed -$1.29M
MYCC
317
DELISTED
ClubCorp Holdings, Inc.
MYCC
– –
-79,561
Closed -$1.28M
AMRI
318
DELISTED
Albany Molecular Research Inc
AMRI
– –
-1,234,440
Closed -$17.3M
KATE
319
DELISTED
Kate Spade & Company
KATE
– –
-60,083
Closed -$1.4M
CEB
320
DELISTED
CEB Inc.
CEB
– –
-288,912
Closed -$22.7M
FNSR
321
DELISTED
Finisar Corp
FNSR
– –
-33,914
Closed -$927K
9 10 11 12
13

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return

Rice Hall James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Rice Hall James & Associates held 321 positions worth $2.3B, up 12% from $2.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rice Hall James & Associates deployed $141M of net new capital in Q2 2017, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Acadia Healthcare: 610,592 shares worth $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Advanced Energy, an estimated $6.38M trimmed.

  • Rice Hall James & Associates's largest Q2 2017 buy was Acadia Healthcare: 610,592 shares worth $30.2M.
  • Rice Hall James & Associates added most to Supernus Pharmaceuticals in Q2 2017, an estimated $9.54M increase.
  • Rice Hall James & Associates's biggest Q2 2017 reduction was Advanced Energy, cutting an estimated $6.38M.
  • Rice Hall James & Associates fully exited CEB Inc. in Q2 2017, selling an estimated $22.7M.
  • Rice Hall James & Associates's ten largest holdings make up 18% of its $2.3B portfolio in Q2 2017.
  • Rice Hall James & Associates opened 26 new positions and closed 32 in Q2 2017.
  • Rice Hall James & Associates's portfolio value rose 12% quarter-over-quarter to $2.3B.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.